ELRIG Drug Discovery 2026 has ended. This guide stays up as the record of who was there. Next: ELRIG DD 2027, Oct 19–20, 2027 in Liverpool

Large pharma companies at ELRIG Drug Discovery 2026

Oct 14–15, 2026 London, UK ~3k attendees Website

6 large pharma companies are at ELRIG Drug Discovery 2026 — 23 presentations on the program and 2 with a booth in the exhibit hall. Most represented: AstraZeneca (11 on the program), GSK (8 on the program), Eli Lilly (1 on the program). 2 of them have their own page in this guide. As of Oct 8, 2026.

All 388 organizations at ELRIG Drug Discovery 2026 →

Showing 1–6 of 6 organizations

Organization	ELRIG Drug Discovery 2026 Attendance
AstraZeneca Cambridge, UK	◆Partner
astrazeneca.com Large pharmaPartner Global biopharmaceutical company discovering and developing medicines in oncology, rare disease, and cardiovascular, renal, metabolic and respiratory disease.	Booth Exhibiting at Booth CZ01 Wed, Oct 148:00am–7:00pmThu, Oct 158:00am–4:00pm Chair Wed Oct 14 11:15am–11:20am Track Chair - CRISPR/Cas technologies from discovery to therapeutic application How CRISPR gene editing is used from finding drug targets to engineering cell and gene therapies, and where it may go next. Tech Theatre with The Francis Crick Institute Chair Wed Oct 14 11:15am–11:20am Track Chair - Next-gen biophysics How biophysics has shaped drug discovery from checking targets to refining lead compounds, and how newer methods can speed programmes up. Auditorium 4 with Domainex Talk Wed Oct 14 11:20am–11:50am From Design Space to Data Space: An AI-Driven Approach to Better Cell Models and Smarter Assays Auditorium 2 Integrating experimental design, lab-in-the-loop and AI towards translatable discovery Talk Wed Oct 14 11:50am–12:20pm Automating In Vivo Antibody Discovery How a manual B-cell processing workflow was automated to reduce operator variability and raise throughput while preserving cell quality. Exhibition Hall Theatre with Hamilton Talk Wed Oct 14 12:20pm–12:50pm Finding Small Molecule Tools in Compound Pools using Surface Plasmon Resonance Auditorium 4 Next-gen biophysics Talk Wed Oct 14 2:40pm–3:10pm Transforming Targeted Therapeutics: Innovation in ADC Bioconjugation and Radioligands Auditorium 3 Targeted potency: Advances in radioligands and bioconjugates Talk Wed Oct 14 3:10pm–3:45pm To PhD or not to PhD? Navigating Life Sciences careers as an ECP Whether early career scientists gain more from a doctorate or from hands-on experience, and how people actually build life science careers. Learning Zone Panel Wed Oct 14 4:30pm–5:00pm Panel session - The Future of AI and Design of Experiments in Drug Discovery Auditorium 2 Integrating experimental design, lab-in-the-loop and AI towards translatable discovery · with Cambridge Consultants, IQVIA Talk Wed Oct 14 4:30pm–5:00pm Rewriting Disease-Causing Variants: Templated Editing In Vivo Tech Theatre CRISPR/Cas technologies from discovery to therapeutic application Talk Thu Oct 15 12:40pm–1:10pm The AstraZeneca Global Cell Bank: Powering Consistent and Compliant Drug Discovery Auditorium 4 From sample to translation: Solving the practical challenges of modern drug discovery Talk Thu Oct 15 3:30pm–4:00pm (AI)straZeneca: Case Studies in the Integration of Machine Learning and Medicinal Chemistry Auditorium 3 AI in medicinal chemistry
GSK London, UK	◆Partner
gsk.com Large pharmaPartner Global biopharmaceutical company developing vaccines and specialty medicines in infectious disease, HIV, respiratory, immunology and oncology.	Booth Exhibiting at Booth CZ02 Wed, Oct 148:00am–7:00pmThu, Oct 158:00am–4:00pm Chair Wed Oct 14 11:15am–11:20am Track Chair - Engineering the cell microenvironment: Cell-based models for drug discovery How engineered cell surroundings, from three-dimensional cultures to immune-competent models, help lab assays better predict what happens in patients. Auditorium 1 with Nottingham Trent University Talk Wed Oct 14 11:20am–11:50am Biophysics: A Look Back at Changing Tools and Changing Questions Auditorium 4 Next-gen biophysics Talk Wed Oct 14 2:00pm–2:30pm Designing Smarter Experiments: Connecting DoE, Laboratory Automation and AI in a Translational Discovery Workflow Auditorium 2 Integrating experimental design, lab-in-the-loop and AI towards translatable discovery Talk Wed Oct 14 2:00pm–2:30pm Sarcoma patient derived 3D cell culture models for drug discovery and prediction of the clinical trials outcome Auditorium 1 Engineering the cell microenvironment: Cell-based models for drug discovery Talk Wed Oct 14 2:40pm–3:10pm Patient-Derived Intestinal Organoids: Advancing Gut Complexity for Drug Discovery and Development Auditorium 1 Engineering the cell microenvironment: Cell-based models for drug discovery Talk Wed Oct 14 5:30pm–6:30pm Early Career Professionals: Network Like A Boss Meeting other early career professionals in speed networking rounds to build the contacts a drug discovery career depends on. Learning Zone with Liverpool School of Tropical Medicine Panel Thu Oct 15 9:30am–10:15am Keynote Panel - 20 Years of Discovery: Lessons from the Past, Blueprints for the Next 20 What two decades of change in drug discovery, from high-throughput screening to AI design, teach about building the next generation of medicines. Auditorium 1 with Constructive Bio, Omega Funds, OtoImmune +1 more Talk Thu Oct 15 2:30pm–3:00pm Automated Molecular Design in BRADSHAW: Application to GSK Projects Auditorium 3 AI in medicinal chemistry
Eli Lilly Indianapolis, Indiana
lilly.com Large pharma Global pharmaceutical company with medicines in diabetes, obesity, oncology, immunology and neuroscience.	Talk Wed Oct 14 4:30pm–5:00pm The pharmacology of orforglipron, an orally bioavailable, non-peptide agonist of the GLP-1 receptor Exhibition Hall Theatre Translating ideas into therapies - Navigating the challenges
Moderna Cambridge, MA
modernatx.com Large pharma mRNA medicines company with marketed vaccines and a pipeline spanning infectious disease, oncology and rare disease.	Chair Thu Oct 15 10:50am–10:55am Track Chair - From multi-omics to clinical outcomes: Insights for drug development How much molecular data and how many participants early studies need, and which signals from large biological datasets can be trusted. Auditorium 1 with Amphista Therapeutics
Novartis Basel, Switzerland
novartis.com Large pharma Global pharmaceutical company developing innovative medicines across major therapeutic areas.	Chair Wed Oct 14 9:20am–9:25am Conference Director Welcome & Keynote Introduction Auditorium 1 Engineering the cell microenvironment: Cell-based models for drug discovery · with Black Medical and Scientific Network, LifeArc, Novo Nordisk
Novo Nordisk Bagsværd, Denmark
novonordisk.com Large pharma Global pharmaceutical company focused on diabetes, obesity and other serious chronic diseases.	Chair Wed Oct 14 9:20am–9:25am Conference Director Welcome & Keynote Introduction Auditorium 1 Engineering the cell microenvironment: Cell-based models for drug discovery · with Black Medical and Scientific Network, LifeArc, Novartis